In our study, we assessed the diagnostic accuracy of certain non-invasive scores currently being used for diagnosing liver fibrosis (AST/ALT ratio, APRI score, FIB-4 index, BARD score, NAFLD-fibrosis score. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.